We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
A 2014 court ruling found that any drug is entitled to an exclusivity period if it has been designated as an orphan drug for a qualifying condition or disease and also approved for marketing. Read More
The agency plans to issue proposed rule to require a new form of patient labeling for prescription drugs dispensed or administered on an out-patient basis. Read More